| Literature DB >> 31546663 |
Chang-Liang Jing1, Rui-Huan Huang2, Yan Su3, Yi-Qiang Li4, Cheng-Sheng Zhang5.
Abstract
Flos Chrysanthemi indici, an important medicinal and aromatic plant in China, is considered to have many different preservative and pharmacological properties. Considering the capability of essential oils (EOs), the present study is conducted to compare different extraction methods in order to improve yield and biological activities. Hydro-distillation (HD), steam-distillation (SD), solvent-free microwave extraction (SFME), and supercritical fluid extraction (SFE) are employed to prepare EOs from Flos Chrysanthemi indici. A total of 71 compounds are assigned by gas chromatography/mass spectrometry (GC-MS) in comparison with retention indices. These include 32 (HD), 16 (SD), 31 (SFME) and 38 (SFE) compounds. Major constituents of EOs differ according to the extraction methods were heptenol, tricosane, camphor, borneol, and eucalyptol. EOs extracted by SFME exhibit higher antioxidant activity. All EOs show varying degrees of antimicrobial activity, with minimum inhibitory concentration (MIC) ranging from 0.0625 to 0.125 mg/mL and SFME and SFE prove to be efficient extraction methods. EOs alter the hyphal morphology of Alternaria alternata, with visible bumps forming on the mycelium. Overall, these results indicate that the extraction method can significantly influence the composition and biological activity of EOs and SFME and SFE are outstanding methods to extract EOs with high yield and antimicrobial activity.Entities:
Keywords: Flos Chrysanthemi indici; biological activity; chemical composition; essential oil; extraction method
Year: 2019 PMID: 31546663 PMCID: PMC6843213 DOI: 10.3390/biom9100518
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X
Figure 1Changes in essential oil yields (%, v/w) of Flos Chrysanthemi indici under different extraction methods.
Figure 2Numbers of the classes of compounds in extracts obtained by different extraction methods.
Volatile compounds identified in extracts of Flos Chrysanthemi indici prepared by different extraction methods.
| No. | Name of Compound | Molecular Weight | CAS Number | Extraction Method a | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| HD | SD | SFME | SFE | ||||||||
| RT b | %A c | RT | %A | RT | %A | RT | %A | ||||
| 1 | Camphene | 136.125 | 000079-92-5 | 9.642 | 0.42 ± 0.05 | n.i | n.i | n.i | n.i | n.i | n.i |
| 2 | Eucalyptol | 154.136 | 000470-82-6 | 11.388 | 3.59 ± 1.64 | 11.418 | 11.38 ± 2.47 | 11.38 | 0.69 ± 0.04 | 11.38 | 0.95 ± 0.96 |
| 3 | 1,4-Cyclohexadiene, 1-methyl-4-(1-methylethyl)- | 136.125 | 000099-85-4 | 11.862 | 0.22 ± 0.05 | 11.862 | 0.28 ± 0.29 | n.i | n.i | n.i | n.i |
| 4 | Methyl ethyl cyclopentene | 110.11 | 019780-56-4 | n.i | n.i | n.i | n.i | 12.75 | 0.66 ± 0.21 | 12.746 | 0.66 ± 0.78 |
| 5 | ( | 110.11 | 007348-80-3 | 12.754 | 1.45 ± 2.28 | 12.767 | 2.40 ± 0.47 | n.i | n.i | n.i | n.i |
| 6 | lsobenzofuranone | 182.094 | 054346-06-4 | 12.923 | 1.32 ± 0.47 | 12.936 | 1.97 ± 2.25 | 12.919 | 0.86 ± 0.98 | 12.923 | 0.57 ± 0.41 |
| 7 | ( | 96.058 | 053497-80-6 | 13.718 | 2.34 ± 1.12 | n.i | n.i | n.i | n.i | n.i | n.i |
| 8 | 1,7-Octadiene, 3,6-dimethylene | 134.11 | 003382-59-0 | n.i | n.i | n.i | n.i | 13.722 | 2.99 ± 0.74 | n.i | n.i |
| 9 | 4-Ethyl-2-hexynal | 124.089 | 071932-97-3 | n.i | n.i | 13.743 | 2.30 ± 0.87 | n.i | n.i | n.i | n.i |
| 10 | endo-Borneol | 154.136 | 000507-70-0 | n.i | n.i | n.i | n.i | n.i | n.i | 13.866 | 1.55 ± 0.06 |
| 11 | Borneol | 154.136 | 010385-78-1 | 13.909 | 7.07 ± 1.17 | 13.925 | 5.22 ± 2.74 | 13.913 | 8.01 ± 2.44 | n.i | n.i |
| 12 | 4-methyl-1-(1-methylethyl)-3-Cyclohexen-1-ol | 154.136 | 000562-74-3 | n.i | n.i | 14.018 | 1.20 ± 0.24 | n.i | n.i | n.i | n.i |
| 13 | 1-butenylidene-Cyclohexane | 136.125 | 036144-40-8 | 14.234 | 1.05 ± 0.25 | n.i | n.i | 14.234 | 0.96 ± 0.47 | n.i | n.i |
| 14 | heptenol | 194.131 | 1000195-66-0 | 14.746 | 17.99±1.25 | n.i | n.i | 14.746 | 16.66±2.31 | 14.716 | 6.93± 0.09 |
| 15 | tert-butyl-Benzene | 134.11 | 000098-06-6 | n.i | n.i | 15.13 | 24.12±2.36 | 14.746 | 0.15 ± 0.47 | n.i | n.i |
| 16 | Bicyclo[3.1.1]hept-2-en-6-ol, 2,7,7-trimethyl-, acetate, [1S-(1. 1α,5α,6β)]- | 194.131 | 050764-55-1 | n.i | n.i | n.i | n.i | 15.122 | 1.71 ± 1.21 | n.i | n.i |
| 17 | Bornyl acetate | 196.146 | 000076-49-3 | 15.545 | 2.06 ± 0.04 | 15.558 | 3.15 ± 2.14 | 15.545 | 1.33 ± 0.05 | 15.537 | 1.51 ± 0.23 |
| 18 | Cosmene | 134.11 | 000460-01-5 | 16.074 | 0.28 ± 0.06 | 16.078 | 0.26 ± 0.12 | n.i | n.i | n.i | n.i |
| 19 | Caryophyllene | 204.188 | 000087-44-5 | n.i | n.i | 17.473 | 0.43 ± 0.25 | n.i | n.i | 17.469 | 0.31 ± 0.01 |
| 20 | Isocaryophyllene | 204.188 | 000118-65-0 | n.i | n.i | n.i | n.i | n.i | n.i | 17.765 | 0.68 ± 0.99 |
| 21 | a-Gurjunene | 204.188 | 000489-40-7 | 18.137 | 0.27 ± 0.01 | n.i | n.i | 18.137 | 0.28 ± 0.04 | n.i | n.i |
| 22 | Curcumene | 202.172 | 000644-30-4 | 18.179 | 0.58 ± 0.11 | n.i | n.i | 18.184 | 0.84 ± 0.31 | 18.175 | 0.33 ± 0.11 |
| 23 | Naphthalene | 204.188 | 000473-13-2 | 18.37 | 1.28 ± 0.25 | n.i | n.i | 18.441 | 3.26 ± 1.02 | 18.366 | 0.21 ± 0.14 |
| 24 | Spathulenol | 204.188 | 025246-27-9 | n.i | n.i | n.i | n.i | 18.37 | 1.12 ± 0.08 | n.i | n.i |
| 25 | 1,1,7-Trimethyl-4-methylenedec ahydro-1 | 204.188 | 025246-27-9 | 18.37 | 0.53 ± 0.25 | n.i | n.i | 18.37 | 1.49 ± 0.79 | n.i | n.i |
| 26 | trans-β-Farnesene | 204.188 | 018794-84-8 | 18.251 | 2.66 ± 0.17 | 18.725 | 0.33 ± 0.45 | 20.213 | 5.07 ± 2.14 | n.i | n.i |
| 27 | ( | 150.141 | 074744-32-4 | n.i | n.i | n.i | n.i | n.i | n.i | 19.528 | 1.23 ± 0.28 |
| 28 | Caryophyllene oxide | 220.183 | 001139-30-6 | 19.541 | 4.23 ± 1.11 | 19.537 | 1.09 ± 0.52 | 19.554 | 7.33 ± 1.28 | n.i | n.i |
| 29 | ( | 204.188 | 1000293-03-2 | n.i | n.i | n.i | n.i | 20.213 | 1.0 ± 0.04 | n.i | n.i |
| 30 | 1 | 204.188 | 1000140-07-3 | 20.416 | 1.35 ± 0.28 | n.i | n.i | n.i | n.i | n.i | n.i |
| 31 | 220.183 | 1000131-71-2 | 20.501 | 0.49 ± 0.74 | n.i | n.i | n.i | n.i | 20.818 | 0.39 ± 0.08 | |
| 32 | 204.188 | 013474-59-4 | 20.97 | 3.76 ± 0.45 | n.i | n.i | n.i | n.i | n.i | n.i | |
| 33 | 2,6-dimethyl-6-(4-methyl-3-pentenyl)-Bicyclo [3.1.1] hept-2-ene | 204.188 | 017699-05-7 | n.i | n.i | n.i | n.i | 20.974 | 4.98 ± 2.47 | n.i | n.i |
| 34 | 1,3-Bis-(2-cyclopropyl, 2-methylcyclopropyl)-but-2-en-1-one | 258.198 | 1000222-08-6 | n.i | n.i | n.i | n.i | n.i | n.i | 20.975 | 1.31± 0.04 |
| 35 | 1,7,7-Trimethylbicyclo [2.2.1] hept-5-en-2-one | 150.104 | 022516-10-5 | 21.288 | 5.89 ± 0.87 | 21.266 | 0.67 ± 0.12 | 21.296 | 8.18 ± 2.14 | 21.262 | 3.90 ± 1.25 |
| 36 | Camphor | 150.104 | 022516-10-5 | 21.288 | 23.53±5.21 | 21.266 | 39.71±2.89 | 21.296 | 13.51±1.57 | 21.262 | 7.14 ± 2.36 |
| 37 | Naphthalenone | 218.167 | 091416-23-8 | 21.381 | 1.59 ± 0.21 | n.i | n.i | 1.34 ± 0.51 | n.i | n.i | |
| 38 | 6,6-Dimethyl-2-vinylidenebicyclo [3.1.1] heptane | 148.125 | 039021-75-5 | n.i | n.i | n.i | n.i | 21.389 | 2.31 ± 0.58 | n.i | n.i |
| 39 | 5-benzyloxy-Pent-1-yne | 174.104 | 057618-47-0 | 21.609 | 1.27 ± 0.28 | n.i | n.i | n.i | n.i | n.i | n.i |
| 40 | octahydro-1,4,9,9-tetramethyl-1 | 206.203 | 025491-20-7 | 21.93 | 0.34 ± 0.14 | n.i | n.i | 21.93 | 1.05 ± 0.43 | 21.93 | 0.22 ± 0.08 |
| 41 | 1,5-Heptadiyne | 92.063 | 000764-56-7 | n.i | n.i | n.i | n.i | n.i | n.i | 22.07 | 1.06 ± 0.41 |
| 42 | Phenylethyne | 102.047 | 000536-74-3 | n.i | n.i | n.i | n.i | n.i | n.i | 23.152 | 0.25 ± 0.09 |
| 43 | 2,3-dihydroxy-1 | 214.038 | 023774-23-4 | 23.512 | 1.34 ± 0.96 | n.i | n.i | 23.512 | 4.76 ± 1.12 | 23.512 | 7.63 ± 1.25 |
| 44 | 2,3,4,5-tetramethyl-Tricyclo [3.2.1.02,7] oct-3-ene | 162.141 | 062338-44-7 | n.i | n.i | n.i | n.i | n.i | n.i | 23.668 | 7.62 ± 1.47 |
| 45 | Octacosane | 394.454 | 000630-02-4 | n.i | n.i | n.i | n.i | n.i | n.i | 24.789 | 1.81 ± 0.21 |
| 46 | Heneicosane | 296.344 | 000629-94-7 | 24.793 | 0.81 ± 0.22 | n.i | n.i | 24.793 | 1.10 ± 0.17 | n.i | n.i |
| 47 | Linoleic acid | 294.256 | 002566-97-4 | n.i | n.i | n.i | n.i | 24.729 | ± 0.03 | 25.106 | 2.22 ± 0.09 |
| 48 | 7,10,13-Hexadecatrienoic acid, methyl ester | 264.209 | 056554-30-4 | n.i | n.i | n.i | n.i | n.i | n.i | 25.161 | 3.45 ± 1.12 |
| 49 | Cyclododecyne | 164.157 | 001129-90-4 | 25.313 | 0.56 ± 0.12 | n.i | n.i | n.i | n.i | 25.313 | 1.75 ± 0.25 |
| 50 | Tricosane | 324.376 | 000638-67-5 | 26.569 | 0.96 ± 0.08 | n.i | n.i | 26.573 | 1.25 ± 0.21 | 26.573 | 4.03 ± 1.25 |
| 51 | 1-(2,2-dimethyl-1-phenylethynylcyclopropyl)-Ethanol | 214.136 | 1000268-53-7 | n.i | n.i | n.i | n.i | n.i | n.i | 26.641 | 5.31± 0.14 |
| 52 | Acetic acid, 9,9-dioxo-9-thiabicyclo [3.3.1] non-6-en-2-yl ester | 230.061 | 1000185-79-6 | n.i | n.i | n.i | n.i | n.i | n.i | 27.005 | 2.86 ± 0.89 |
| 53 | Pentacosane | 352.407 | 000629-99-2 | 28.206 | 0.34 ± 0.08 | n.i | n.i | 28.205 | 0.45 ± 0.22 | 28.206 | 4.56 ± 1.12 |
| 54 | 2-Hexenedioic acid, 2-methoxy-, dimethyl ester | 202.084 | 056114-71-7 | n.i | n.i | n.i | n.i | n.i | n.i | 28.903 | 1.06 ± 0.95 |
| 55 | 355.182 | 1000282-52-4 | n.i | n.i | n.i | n.i | n.i | n.i | 29.254 | 1.26 ± 0.02 | |
| 56 | Hentriacontane | 436.501 | 000630-04-6 | n.i | n.i | n.i | n.i | n.i | n.i | 29.719 | 1.10 ± 0.29 |
| 57 | Eicosane | 282.329 | 000112-95-8 | n.i | n.i | n.i | n.i | n.i | n.i | 31.132 | 0.73 ± 0.28 |
| 58 | 4-Trimethyl-3-hydroxymethyl-5a-(3-methyl-but-2-enyl)-cyclhexene | 222.198 | 1000144-10-5 | 32.185 | 1.79 ± 0.74 | n.i | n.i | n.i | n.i | n.i | n.i |
| 59 | Ursodeoxycholic acid | 392.293 | 000128-13-2 | n.i | n.i | n.i | n.i | n.i | n.i | 35.504 | 0.55± 0.25 |
| 60 | Chola-5,22-dien-3-ol, (3. β.,22 | 342.292 | 057597-14-5 | n.i | n.i | n.i | n.i | n.i | n.i | 35.656 | 1.82 ± 0.87 |
a Relative content of individual compounds are expressed as average relative percent peak area after three replicated (n = 3), b RT-Retention times; c%A—Peak areas, n.i. = not identified.
Antioxidant activities of essential oils (EOs) extracted by different methods.
| Samples | IC50 (mg/mL) | |
|---|---|---|
| DPPH | ABTS | |
| Ascorbic acid | 0.08 ± 0.01a | 0.12 ± 0.02 a |
| HD | 0.53 ± 0.03 c | 1.14 ± 0.08 c |
| SD | 0.58 ± 0.05 c | 0.84 ± 0.07 b |
| SFME | 0.43 ± 0.01 b | 0.75 ± 0.03 b |
| SFE | 0.42 ± 0.03 b | 1.05 ± 0.11 c |
a–c Means in the same row followed by different letters are significantly different (p < 0.05). Each value is represented in terms of mean (n = 3) ± SD (Standard deviation).
Minimal inhibitory concentrations (MIC) of essential oils extracted from Flos Chrysanthemi indici by different methods.
| Method | MIC (µg/mL) | |||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| Positive control | 0.1 | 25.0 | 20.0 | 2.50 | -- | 1.95 |
| HD | 62.5 | 125.0 | 62.5 | 62.5 | 125.0 | 125.0 |
| SD | 125.0 | 125.0 | 62.5 | 125.0 | 125.0 | 125.0 |
| SFME | 62.5 | 125.0 | 62.5 | 62.5 | 125.0 | 62.5 |
| SFE | 62.5 | 62.5 | 62.5 | 125 | 125.0 | 62.5 |
Figure 3Antibacterial activity of EOs extracted from Flos Chrysanthemi Indici evaluated by disk diffusion method.
Figure 4Antifungal bioassay against A. alternata and scanning electron micrographs (10,000×) of the morphology of A. alternata with and without EO treatment. (A) Control group; (B) A. alternate treated with EOs; (C) mycelium of untreated culture (control); (D) mycelium of A. alternata treated with EOs at MIC.